CEPI partners with BioNet to expand variant-proof vaccine programme

CEPI, the Coalition for Epidemic Preparedness Innovations, has announced the latest award under its $200 million pr...

February 1, 2022 | Tuesday | News
Daiichi Sankyo starts trial for mRNA vaccine as booster dose in Japan

Daiichi Sankyo has initiated a trial in Japan to investigate a booster dose of DS-5670, an mRNA vaccine against COVID-19...

January 31, 2022 | Monday | News
Australia approves Pfizer booster for 16–17 year olds

The Therapeutic Goods Administration (TGA) in Australia has approved the Pfizer COVID-19 booster dose for young people a...

January 28, 2022 | Friday | News
National Vaccine Institute of Thailand strengthens partnership with International Vaccine Institute

The International Vaccine Institute (IVI) in South Korea and the National Vaccine Institute (NVI) of Thailand have signe...

January 24, 2022 | Monday | News
Australia grants provisional registration for Novavax COVID-19 vaccine

Novavax, Inc. has announced that Australia's Therapeutic Goods Administration (TGA) has granted approval for p...

January 20, 2022 | Thursday | News
How countries are dealing with 'Vaccine Hesitancy'?

The COVID-19 pandemic may well be the worst public health crisis in modern history. But today, the global health system ...

January 13, 2022 | Thursday | Opinion
South Korea approves Novavax COVID-19 vaccine

US-based Novavax, Inc. and SK bioscience, Co. Limited, a vaccine business subsidiary of Korea-based SK Group, have annou...

January 13, 2022 | Thursday | News
Novavax, Serum Institute of India file for COVID-19 vaccine EUA in South Africa

Novavax, Inc. and Serum Institute of India have announced a regulatory submission to the South African Health Products R...

January 11, 2022 | Tuesday | News
GSK Singapore launches Shingrix vaccine against shingles (herpes zoster)

GlaxoSmithKline (GSK) Singapore has launched a new vaccine to help protect against shingles, Shingrix, in...

January 10, 2022 | Monday | News
Pfizer receives EUA of booster shot for 12-15 age group

Pfizer Inc. and BioNTech SE have announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency U...

January 4, 2022 | Tuesday | News
India's COVAXINÒ exhibits safety in paediatric subjects in Ph II/III study

Indian firm Bharat Biotech International Limited (BBIL), a global leader in vaccine innovation and developer of vaccines...

January 3, 2022 | Monday | News
CEPI backs Korea to develop ‘variant-proof’ vaccine candidate

Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, and South Korean firm SK bioscience (SK) have an...

December 22, 2021 | Wednesday | News
Japan approves booster shot for Moderna COVID-19 vaccine

US-based Brand Institute has announced its successful partnership with Moderna in naming their mRNA COVID-19 vaccine: SP...

December 20, 2021 | Monday | News
Korea issues marketing authorization to Moderna COVID-19 vaccine

American firm Moderna has announced that the Ministry of Food and Drug Safety of Korea (MFDS) has issued a marketing aut...

December 16, 2021 | Thursday | News
HDT Bio initiates RNA COVID-19 vaccine trials in South Korea

HDT Bio Corp., a US-based developer of immunotherapies for oncology and infectious diseases, and Korean biotech Quratis ...

December 14, 2021 | Tuesday | News
Moderna to bring mRNA manufacturing to Australia

US-based Moderna, Inc. has announced an agreement in principle with the Australian Government to build a state-of-the-ar...

December 14, 2021 | Tuesday | News
Hong Kong studies impact of Pfizer vaccine on Omicron variant

A recent study jointly conducted by the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) and the Faculty of...

December 13, 2021 | Monday | News
China’s CanSinoBIO to bring world's first inhalable COVID-19 vaccine

After months of collaborative development, Ireland-based Aerogen and China’s CanSinoBIO have announced a developme...

December 10, 2021 | Friday | News